Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database

PURPOSE: In Switzerland 167 drugs on the market contain information about pharmacogenetics in their drug label (PGx drug). Preemptive pharmacogenetic testing is reimbursed by health care insurance for only seven drugs (abacavir, carbamazepine, 6-mercaptopurine, azathioprine, 5-fluorouracil, capecita...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittwer, Nina L, Meier, Christoph R, Huber, Carola A, Meyer zu Schwabedissen, Henriette E, Allemann, Samuel, Schneider, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701506/
https://www.ncbi.nlm.nih.gov/pubmed/36447837
http://dx.doi.org/10.2147/PGPM.S382214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701506/
https://www.ncbi.nlm.nih.gov/pubmed/36447837
http://dx.doi.org/10.2147/PGPM.S382214

Ejemplares similares